ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2024-03-04  |  UPDATED: 1402/11/15 - 18:13:1 FA | AR | PS | EN
Formation of the Federalist Assembly of Afghanistan             Israel launches missile attack on outskirts of Damascus, killing Syrian civilians             íUK national scandalí: 20,000 mental health patients íraped, sexually assaultedí in NHS care             Three US troops killed, dozens injured in drone attack in Syria             Trump says NATO will not come to rescue if US attacked             Ukraine beset by $40m fraud in arms procurement amid war with Russia            US approves sale of F-16 jets to Turkey after Ankara ratifies Swedenís NATO membership             UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza             Taliban: Afghanistan Does Not Have Formal Border With Pakistan             Gazaís major health facility collapses amid Israeli attacks: MSF             Americans to redeploy nuclear weapons in UK amid fears of WW3             Biden makes history: 1st sitting US president sued for complicity in genocide             Trump walks out of courtroom during closing arguments of Carrollís attorney            US: 3 dead in shooting at Texas apartment complex            US-UK aggression against Yemen risks expansion of war: Iran            


DATE PUBLISHED: 1399/06/26 - 17:15:5
VISIT: 947
SHARE WITH YOUR FRIENDS

Russia to sell 100mn doses of COVID-19 vaccine to India


Russia reportedly reaches a deal to sell its coronavirus vaccine to India. (File photo)

Russiaís sovereign wealth fund has reportedly reached a deal to sell 100 million doses of its COVID-19 vaccine, called Sputnik-V, to a major pharmaceutical company in India.

Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with the company, said a source close to the deal on Wednesday as cited in a Reuters report, which further noted that both the trials and supply deal depend on domestic regulatory approval.

According to the report, the Russian Direct Investment Fund (RDIF) has so far signed vaccine supply deals with Kazakhstan, Brazil and Mexico and has reached a manufacturing partnership agreement with India to produce 300 million doses of the Sputnik-V vaccine there.

The source also noted that RDIF will announce the name of the Indian company later on Wednesday.

Russia introduced Sputnik-V as the first vaccine against coronavirus to be registered in the world. Large-scale trials, known as Phase III trials, involving at least 40,000 people were launched in Russia on August 26.

Positive results in China-UAE phase 3 COVID-19 vaccine trials

This is while Chinese Foreign Ministry spokesman Wang Wenbin also declared during a Wednesday press briefing in Beijing that China and the United Arab Emirates (UAE) have seen some positive results in their Phase III COVID-19 vaccine trials, Chi.

The UAE granted emergency approval for the use of a coronavirus vaccine on Monday, six weeks after human trials in the Persian Gulf Arab state was first launched.

Pfizer COVID-19 vaccine trial reports no major safety issues

Meanwhile, researchers monitoring Pfizer Inc.ís giant trial of an experimental COVID-19 vaccine have reported no safety problems even after more than 12,000 people received their second of two doses, Bloomberg reported Wednesday.

"So far there has been no safety signal reported," said Mikael Dolsten, Pfizerís chief scientific officer, in an online meeting with investors.

The trial, now targeted at enrolling 44,000 people, has reached its initial goal of 30,000 subjects, Pfizer executives added. The drug makers have expanded the trial to allow inclusion of teenagers and people with certain medical conditions, like HIV.

The trial compares two shots of the vaccine Pfizer is co-developing with Germanyís BioNTech SE to two doses of a placebo. While the doctors and subjects in the trial donít know who got the vaccine - a measure to avoid bias - a committee of outside experts that knows which people received the shot is reviewing safety data on a weekly basis, Pfizer executives said during the investor meeting.

"They would notify us if they had any safety concerns and have not done that to date," Kathrin Jansen, Pfizerís head of vaccine research, said during the meeting. The companyís own scientists are also looking for worrisome adverse events that havenít appeared so far. Fatigue has been the most common side effect seen in the trial thus far, according to the Pfizer presentation.

Pfizer confirmed it expects to get conclusive data on the vaccineís efficacy by the end of October. The board monitoring the trial will conduct its first review of the data for efficacy when a total of 32 coronavirus cases have been seen among participants, Pfizer executives said during the investor meeting.

The company promised to make all its safety and efficacy data publicly available should it seek emergency authorization for the vaccine.

"What we are doing in terms of releasing data is very unusual," Chief Executive Officer Albert Bourla said on a call with the press, citing ongoing conversations with US regulators and Congress. "It is a must to release this data."

Potential nasal spray COVID-19 vaccine in China clinical trial

Moreover, China has also begun human trials of a nasal spray COVID-19 candidate vaccine that could serve as an alternative to injections.

The vaccine has become the first of its kind in the world to proceed to the clinical trial phase, according to the WHOís list of candidate vaccines released last Wednesday.

Scientists hope that the vaccine puffed into the nose could be effective in preventing the coronavirus, which spreads through the respiratory tract.

It could be delivered along with an injected vaccine to mount a multi-pronged approach.

Another advantage of the nasal spray vaccine is that it can be easily self-administered.

The vaccine has been co-developed by HKU, Fujian Provinceís Xiamen University, and vaccine-maker Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

Germany: Coronavirus vaccine likely available by mid-2021

The German government is also expecting to make available a COVID-19 vaccine for parts of its population early next year, with three firms due to be subsidized by the government to research potential vaccines.

German Health Minister Jens Spahn and Research Minister Anja Karliczek announced during a Berlin press briefing on Tuesday that they expected a COVID-19 vaccine to be ready next year, adding that research by three German companies - BioNTech, CureVac, and IDT Biologika - was currently being funded.

But the ministers both warned that "risky shortcuts" would not be taken, that a vaccine would not be available to most the population until the middle of next year. "We want a safe and effective vaccine, not necessarily to be the first," Spahn said.

"Safety has absolute priority on this point," Karliczek added.

 

LINK: https://www.ansarpress.com/english/20281


TAGS:






*
*

*



SEE ALSO

íUK national scandalí: 20,000 mental health patients íraped, sexually assaultedí in NHS care


US: 3 dead in shooting at Texas apartment complex


UN agency says over half a million Palestinians face Ďcatastrophic hungerí in Gaza


Survivors of Russian charter flight crash transferred to Kabul


Pro-Israel lobby ousted ABC journalist, prompting staff to call for industrial action


UNICEF: Afghan earthquakes leave 100,000 children in urgent need of aid this winter


Thousands rage in Toronto against Israeli genocide as Gaza war marks 100 days


Thousands rally in front of White House to demand ceasefire in Gaza


Increased Taliban arrests lead to Kabul families restricting womenís movement


Taliban arrests dozens of women in Kabul for Ďimproper hijab,í says womenís group





VIEWED
MOST DISCUSSED




POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

Federalism in Afghanistan: Opportunities and Challenges

Formation of the Federalist Assembly of Afghanistan

Israel launches missile attack on outskirts of Damascus, killing Syrian civilians

íUK national scandalí: 20,000 mental health patients íraped, sexually assaultedí in NHS care

Three US troops killed, dozens injured in drone attack in Syria

Trump says NATO will not come to rescue if US attacked

Ukraine beset by $40m fraud in arms procurement amid war with Russia

US approves sale of F-16 jets to Turkey after Ankara ratifies Swedenís NATO membership

UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza

Taliban: Afghanistan Does Not Have Formal Border With Pakistan

Gazaís major health facility collapses amid Israeli attacks: MSF

Americans to redeploy nuclear weapons in UK amid fears of WW3

Biden makes history: 1st sitting US president sued for complicity in genocide

Trump walks out of courtroom during closing arguments of Carrollís attorney

US: 3 dead in shooting at Texas apartment complex

US-UK aggression against Yemen risks expansion of war: Iran

Yemen directly hits US warship with ballistic missile

Hamas has self-reliantly opposed the three giant intelligence agencies of the world!

President Raeisi calls for UN reform, says body unable to end Gaza genocide

Pedram: The Abduction of Hazara and Tajik Women Recalls the Crimes of Abdur Rahman

Special envoys from G7 countries discuss Afghanistan in London meeting

Turkish lawmakers open debate over Swedenís NATO membership

UN agency says over half a million Palestinians face Ďcatastrophic hungerí in Gaza

Palestinian Islamic Jihad: Al-Maghazi operation proved defeat of Israeli regime in Gaza war

European support for Israel damaging energy security on the continent, report says

Pakistan Army Kills Seven ĎTerroristsí Near Afghan Border

Israel kills at least 190 people in Khan Younis in 24 hours

UNAMA report: 49 Hazara community members killed in Afghanistan in three months

Indiaís Modi inaugurates Hindu temple on site of razed mosque ahead of elections

US 2024 election: DeSantis drops out of Republican presidential race, backs Trump

Survivors of Russian charter flight crash transferred to Kabul

Iranís anti-terror strikes Ďclear messageí to certain recipients: Foreign Ministry

Ethnic mass killings in one Sudan city last year left up to 15,000 dead: UN report

Iran says reserves right to avenge Israelís assassination of IRGC advisors

Rocket barrage targets Ain al-Asad base housing US forces in western Iraq

Lebanese media: Israeli drone kills 2 Hamas members in southern Lebanon

Five IRGC advisors assassinated in Israeli aggression on Syria

Pakistan recalls ambassador from Tehran

Iraqi PM stresses to NATO chief ending of foreign troops

UN chief reiterates call for immediate ceasefire in Gaza


MEDICAL NEWS


ANSAR PRESS ©  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. ›—ś‘ź«Ś «یš —š ی šŕŠ»šŌ«š